Back in October of 2009 both Pfizer and J and J had invested in NovoCure. The electrodes tackle the cancer cells only and healthy cells are left alone. Compared to chemotherapy it offers a better quality of life with brain tumors but you need to be connected almost all the time and carry around the 7 pound battery pack. The system is completely non invasive.
Pfizer Along With Johnson and Johnson Invest in Cancer Medical Device - Novo-Cure Stopping Growth of Tumor and Potential Reversal
Perhaps as time moves forward the device and battery pack will get smaller. BD
A new treatment for a deadly form of brain cancer has been approved by the FDA and is cleared for sale in the U.S. market.
The NovoTTF-100A System (NovoTTF) made by NovoCure is a "non-invasive device consisting of four sets of insulated electrodes attached to an electronic box," according to the privately-held Israeli company.
The FDA's neurological devices panel last month voted 7-to-3, with 2 abstentions, that there is reasonable assurance that the benefits of the device outweigh its risks when "administered as a monotherapy in place of standard medical therapy" for treatment of for treating the brain cancer glioblastoma multiforme (GBM), according to a prepared release from the company